Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Guiju Cai, Xiangyan Ruan, Muqing Gu, Yue Zhao, Yuejiao Wang & Alfred O. Mueck. (2020) PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study. Gynecological Endocrinology 36:11, pages 1024-1027.
Read now
Read now
X. Li, X. Ruan, M. Gu & A. O. Mueck. (2019) PGRMC1 can trigger estrogen-dependent proliferation of breast cancer cells: estradiol vs. equilin vs. ethinylestradiol. Climacteric 22:5, pages 483-488.
Read now
Read now
Harald Seeger, Xiangyan Ruan, Hans Neubauer, Sara Brucker & Alfred O. Mueck. (2018) Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells. Gynecological Endocrinology 34:4, pages 353-356.
Read now
Read now
Ying Zhang, Xiangyan Ruan, Marina Willibald, Harald Seeger, Tanja Fehm, Hans Neubauer & Alfred O. Mueck. (2016) May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?. Gynecological Endocrinology 32:1, pages 58-60.
Read now
Read now
Hannat Akintomide & Sabeena Panicker. (2015) Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability. Open Access Journal of Contraception 6, pages 77-86.
Read now
Read now
Shunyu Liu, Xiangyan Ruan, Silke Schultz, Hans Neubauer, Tanja Fehm, Harald Seeger & Alfred O. Mueck. (2015) Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens. The European Journal of Contraception & Reproductive Health Care 20:1, pages 29-35.
Read now
Read now
H. Neubauer, Q. Ma, J. Zhou, Q. Yu, X. Ruan, H. Seeger, T. Fehm & A. O. Mueck. (2013) Possible role of PGRMC1 in breast cancer development. Climacteric 16:5, pages 509-513.
Read now
Read now
Helen Schneck, Xiangyan Ruan, Harald Seeger, Michael A. Cahill, Tanja Fehm, Alfred O. Mueck & Hans Neubauer. (2013) Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological Endocrinology 29:2, pages 160-162.
Read now
Read now
Articles from other publishers (16)
Juan Yin, Jing Wang, Xinxin Zhang, Yan Liao, Wei Luo, Sha Wang, Jiawei Ding, Jie Huang, Mengling Chen, Wei Wang, Shencun Fang & Jie Chao. (2022) A missing piece of the puzzle in pulmonary fibrosis: anoikis resistance promotes fibroblast activation. Cell & Bioscience 12:1.
Crossref
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Crossref
Hammad Ghafoor, Han Chu, Jie Huang, Mengling Chen, Sha Wang, Jing Wang & Jie Chao. (2022) ZC3H4 promotes pulmonary fibrosis via an ER stress-related positive feedback loop. Toxicology and Applied Pharmacology 435, pages 115856.
Crossref
Crossref
Diego A. Pedroza, Ramadevi Subramani, Kira Tiula, Anthony Do, Navya Rashiraj, Adriana Galvez, Animesh Chatterjee, Alejandra Bencomo, Servando Rivera & Rajkumar Lakshmanaswamy. (2021) Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation. Laboratory Investigation 101:6, pages 733-744.
Crossref
Crossref
Xiangyan Ruan, Guiju Cai, Yun Wei, Muqing Gu, Ying Zhang, Yue Zhao & Alfred O. Mueck. (2020) Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers. Menopause 27:2, pages 183-193.
Crossref
Crossref
Xiangyan Ruan, Muqing Gu, Guiju Cai, Yue Zhao, Lijuan Wang, Xue Li & Alfred O. Mueck. (2019) Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study. Maturitas 123, pages 1-8.
Crossref
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Crossref
Marina Willibald, Giuliano Bayer, Vanessa Stahlhut, Gereon Poschmann, Kai Stühler, Berthold Gierke, Michael Pawlak, Harald Seeger, Alfred O. Mueck, Dieter Niederacher, Tanja Fehm & Hans Neubauer. (2017) Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells. Oncotarget 8:42, pages 72480-72493.
Crossref
Crossref
Yue Zhao, Xiangyan Ruan, Husheng Wang, Xue Li, Muqing Gu, Lijuan Wang, Yanglu Li, Harald Seeger & Alfred O. Mueck. (2017) The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model. Maturitas 102, pages 26-33.
Crossref
Crossref
A-ying Ma, Shu-wu Xie, Jie-yun Zhou & Yan Zhu. (2017) Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a. International Journal of Molecular Sciences 18:7, pages 1337.
Crossref
Crossref
Xiangyan Ruan, Ying Zhang, Alfred O. Mueck, Marina WillibaldHarald Seeger, Tanja FehmSara Brucker & Hans Neubauer. (2017) Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer. Menopause 24:2, pages 203-209.
Crossref
Crossref
Michael A. Cahill, Jalal A. Jazayeri, Susan M. Catalano, Shinya Toyokuni, Zaklina Kovacevic & Des R. Richardson. (2016) The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1866:2, pages 339-349.
Crossref
Crossref
A.O. Mueck & H. Seeger. (2014) Risiko von Brustkrebs unter „hormone replacement therapy“Risk of breast cancer with hormone replacement therapy. Gynäkologische Endokrinologie 12:3, pages 149-155.
Crossref
Crossref
A.O. Mueck, X. Ruan, H. Seeger, T. Fehm & H. Neubauer. (2014) Genomic and non-genomic actions of progestogens in the breast. The Journal of Steroid Biochemistry and Molecular Biology 142, pages 62-67.
Crossref
Crossref
Jing Zhou, Qi Yu, Rong Chen, Harald Seeger, Tanja Fehm, Michael A. Cahill, Alfred O. Mueck & Hans Neubauer. (2013) Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas 76:2, pages 129-133.
Crossref
Crossref
Hans Neubauer, Xiangyan Ruan, Helen Schneck, Harald Seeger, Michael A. Cahill, Yayun Liang, Benfor Mafuvadze, Salman M. Hyder, Tanja Fehm & Alfred O. Mueck. (2013) Overexpression of progesterone receptor membrane component 1. Menopause 20:5, pages 504-510.
Crossref
Crossref